Chair: D. Linz (Maastricht, NL), N. Voigt (Göttingen)
| 10:00 | (V488) | Einleitung |
| N. Voigt (Göttingen) | ||
| 10:05 | (V489) | Atrial metabolism as determinant of electrical and structural remodelling in atrial fibrillation |
| S. Verheule (Maastricht, NL) | ||
| 10:20 | Diskussion | |
| 10:25 | (V490) | Mitochondria: New players in atrial fibrillation |
| B. Brundel (Amsterdam, NL) | ||
| 10:40 | Diskussion | |
| 10:45 | (V491) | Metabolic syndrome and its arrhythmogenic role in heart failure with preserved ejection fraction (HFpEF) |
| F. Hohendanner (Berlin) | ||
| 11:00 | Diskussion | |
| 11:05 | (V492) | Diabetes and arrhythmia: Can novel anti-diabetic therapies impact on electrical and mechanical cardiac function? |
| M. Lehrke (Aachen) | ||
| 11:20 | Diskussion | |
| 11:25 | (V493) | Zusammenfassung |
| D. Linz (Maastricht, NL) |
